🔎 Trials Near Me

Home › Esophageal Cancer › New York › Syracuse

Esophageal Cancer clinical trials in Syracuse, NY

4 studies for Esophageal Cancer are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

RecruitingPhase 1/2
  • Hematology-Oncology Associates of Central NY, P.C. ( Site 4925), East Syracuse · 4 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05319730

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

RecruitingPhase 1/2
  • Hematology-Oncology Associates of Central NY, P.C. ( Site 8925), East Syracuse · 4 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06445972

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

RecruitingPhase 1/2
  • Hematology-Oncology Associates of Central NY, P.C. ( Site 6925), East Syracuse · 4 mi away
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06469944

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • Hematology-Oncology Associates of Central New York, Syracuse
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT03526835

About Esophageal Cancer

Early esophageal cancer does not have symptoms. Factors that increase risk include heavy drinking and smoking. Learn how you can reduce your risk.

More about Esophageal Cancer on MedlinePlus

Esophageal Cancer trials in other cities

Other studies in Syracuse

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.